1. Screening of potential cancer-preventing chemicals for inhibition of induction of ornithine decarboxylase in epithelial cells from rat trachea
- Author
-
G J Kelloff, V E Steele, L J Ross, E. L. White, Donald L. Hill, and S M Schmid
- Subjects
Cancer Research ,Eflornithine ,Phenethyl isothiocyanate ,Genistein ,Pharmacology ,Ornithine Decarboxylase ,Ornithine decarboxylase ,chemistry.chemical_compound ,Animals ,Anticarcinogenic Agents ,Enzyme Inhibitors ,Anticarcinogen ,Cell Line, Transformed ,Dose-Response Relationship, Drug ,biology ,Cell growth ,Epithelial Cells ,General Medicine ,Ornithine Decarboxylase Inhibitors ,Rats ,Trachea ,Oncology ,Biochemistry ,chemistry ,Enzyme inhibitor ,Apoptosis ,Enzyme Induction ,Curcumin ,biology.protein ,Drug Screening Assays, Antitumor - Abstract
Sixty-one selected chemicals were evaluated in rat tracheal epithelial (2C5) cells for their capacity to inhibit induction (or inhibit directly) the enzyme ornithine decarboxylase, the activity of which is associated with cell growth and division. a-Difluoromethylornithine (DFMO) was used as a positive control. At non-toxic concentrations, six test compounds had substantial activity (values for IC 50 DFMO/IC 50 compound >1): N-(2-carboxyphenyl)-all-trans-retinamide, ZK 119010 {2-(4-hydroxyphenyl)-3-methyl-1-[6-(1-pyrrolidinyl)hexyl]-1H-indol-5-ol), curcumin, 18-α-olean-12-ene-3β,23,28-triol, genistein and phenethyl isothiocyanate. These should be considered for further development as cancer preventive agents.
- Published
- 1998
- Full Text
- View/download PDF